CoChat

Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis

Open access
Sehrawat, Tejasav S., Arab, Juan P., Liu, Mengfei, Amrollahi, Pouya, Wan, Meihua, Fan, Jia, Nakao, Yasuhiko, Pose, Elisa, Navarro‐Corcuera, Amaia, Dasgupta, Debanjali, Liao, Chieh‐Yu, He, Li, Mauer, Amy S., Avitabile, Emma, Ventura‐Cots, Meritxell, Bataller, Ramon A., Sanyal, Arun J., Chalasani, Naga P., Heimbach, Julie K., Watt, Kymberly D., Gores, Gregory J., Gines, Pere, Kamath, Patrick S., Simonetto, Douglas A., Hu, Tony Y., Shah, Vijay H., Malhi, Harmeet · 2021 · Hepatology
Cited by 80

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and Aims: Alcoholic hepatitis (AH) is diagnosed by clinical criteria, although several objective scores facilitate risk stratification. Extracellular vesicles (EVs) have emerged as biomarkers for many diseases and are also implicated in the pathogenesis of AH. Therefore, we investigated whether plasma EV concentration and sphingolipid cargo could serve as diagnostic biomarkers for AH and inform prognosis to permit dynamic risk profiling of AH subjects. Approach and Results: EVs were isolated and quantified from plasma samples from healthy controls, heavy drinkers, and subjects with end‐stage liver disease (ESLD) attributed to cholestatic liver diseases and nonalcoholic steatohepatitis, decompensated alcohol‐associated cirrhosis (AC), and AH. Sphingolipids were quantified by tandem mass spectroscopy. The median plasma EV concentration was significantly higher in AH subjects (5.38 × 10 11/mL) compared to healthy controls (4.38 × 10 10/mL; P < 0.0001), heavy drinkers (1.28 × 10 11/mL; P < 0.0001), ESLD (5.35 × 10 10/mL; P < 0.0001), and decompensated AC (9.2 × 10 10/mL; P < 0.0001) disease controls. Among AH subjects, EV concentration correlated with Model for End‐Stage Liver Disease score. When EV counts were dichotomized at the median, survival probability for AH subjects at 90 days was 63.0% in the high‐EV group and 90.0% in the low‐EV group (log‐rank P value = 0.015). Interestingly, EV sphingolipid cargo was significantly enriched in AH when compared to healthy controls, heavy drinkers, ESLD, and decompensated AC (P = 0.0001). Multiple sphingolipids demonstrated good diagnostic and prognostic performance as biomarkers for AH. Conclusions: Circulating EV concentration and sphingolipid cargo signature can be used in the diagnosis and differentiation of AH from heavy drinkers, decompensated AC, and other etiologies of ESLD and predict 90‐day survival permitting dynamic risk profiling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31256

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Sehrawat, T. S., Arab, J. P., Liu, M., Amrollahi, P., Wan, M., Fan, J., Nakao, Y., Pose, E., Navarro‐Corcuera, A., Dasgupta, D., Liao, C., He, L., Mauer, A. S., Avitabile, E., Ventura‐Cots, M., Bataller, R. A., Sanyal, A. J., Chalasani, N. P., Heimbach, J. K., Watt, K. D., Gores, G. J., Gines, P., Kamath, P. S., Simonetto, D. A., Hu, T. Y., Shah, V. H., & Malhi, H.
Venue
Hepatology
Published
2020-10-30
Volume
73
Issue
2
Pages
571-585
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W3014916308
Cited by
80
References
3
FWCI
3.87
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.